Congenital thrombophilia (Q41715390)

7 October 2017

1 reference

title

Congenital thrombophilia (English)

1 reference

7 October 2017

1 reference

Walker ID

1

1 reference

7 October 2017

1 September 1997

1 reference

Bailliere's clinical obstetrics and gynaecology

7 October 2017

1 reference

7 October 2017

11

1 reference

7 October 2017

3

1 reference

7 October 2017

431-445

1 reference

Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Guidelines on the investigation and management of thrombophilia. The British Committee for Standards in Haematology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. Maternal and Neonatal haemostasis Working Party of the Haemostasis and Thrombosis Task

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Familial protein S deficiency is associated with recurrent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Development of resistance to activated protein C during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

An evaluation of 200 consecutive patients with spontaneous or recurrent thrombosis for primary hypercoagulable states

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

An update on clinical and basic aspects of the protein C anticoagulant pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Activated protein C resistance caused by Arg506Gln mutation in factor Va

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Modified test for activated protein C resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin III

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Activated protein C sensitivity ratio in pregnant women at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Antithrombin III and procoagulant activity: sex differences and effects of the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Absence of thrombosis in subjects with heterozygous protein C deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Resistance to activated protein C in healthy women taking oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

A prothrombin time-based functional assay of protein S

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Increased fetal loss in women with heritable thrombophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Second-trimester pregnancy loss is associated with activated C resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

World distribution of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Resistance to activated protein C as a basis for venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Influence of demographic factors on antithrombin III activity in a healthy population

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Prevalence of antithrombin deficiency in the healthy population.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Modified APC resistance assay for patients on oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Management of thrombophilia in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980020-X

7 January 2021

10.1016/S0950-3552(97)80020-X

Identifiers

DOI

1 reference

release_qo347lvt2neqpjj6wkjw6io7ki

7 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qo347lvt2neqpjj6wkjw6io7ki

24 November 2022

mapped directly with Wikidata item

PubMed ID

9488784

1 reference

PubMed ID

9488784